Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic Leukemia - Wikidata - awgldk - TriplyDB

Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic Leukemia

Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic Leukemia

http://www.wikidata.org/entity/Q33736847

about

Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic Leukemia

http://www.wikidata.org/entity/Q33736847

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Impact of Aberrant Myeloid Ant ...... l Acute Lymphoblastic Leukemia

@ast

Impact of Aberrant Myeloid Ant ...... l Acute Lymphoblastic Leukemia

@en

type

label

Impact of Aberrant Myeloid Ant ...... l Acute Lymphoblastic Leukemia

@ast

Impact of Aberrant Myeloid Ant ...... l Acute Lymphoblastic Leukemia

@en

prefLabel

Impact of Aberrant Myeloid Ant ...... l Acute Lymphoblastic Leukemia

@ast

Impact of Aberrant Myeloid Ant ...... l Acute Lymphoblastic Leukemia

@en

P1433

Q33736847-2E6C4791-AD7A-42B8-AC72-72B61EACC9F0

P1476

Q33736847-96196E28-5D1D-4899-80B6-D60C5E17B20D

P2093

Q33736847-00D9724A-93A7-4897-A2E0-62ECD255F853

Q33736847-0A37F6F6-5C9A-453D-89D0-806BA8E7A1D6

Q33736847-90856596-1BD4-4CAE-AE51-761ABEA8E2FD

Q33736847-A11EE2BA-1C7A-485E-80AF-9484F877E177

Q33736847-AD49244A-5ABA-4F27-8719-5B5BB0D05E19

Q33736847-B452C1AF-FDFF-4D5E-B4F4-CAE4530A7475

Q33736847-CCB9776D-00C5-4B94-95C1-037CFC2701FA

P2860

Q33736847-0EA8CC10-879C-4B2B-96F6-8EB02709701B

Q33736847-1AA88E7C-614F-4969-8490-ADAFFCFE1D1C

Q33736847-24EC0739-BEBD-426B-9340-29B3B5DABEAB

Q33736847-433BD3DD-0FCF-4EB5-845E-5327EF020DE1

Q33736847-46720D2B-4737-4C5A-AE87-DE20C76D5577

Q33736847-59B36178-2788-4DE6-966C-BF46FBCE9619

Q33736847-679DD237-B838-440D-8918-C361666C22C4

Q33736847-6DDA4AC3-9607-4DDC-8B64-95A94FF3B3E8

Q33736847-83BC2FD4-A5AB-4E26-9AA6-247EC688E1F7

Q33736847-8BF8FC8C-DB4A-48AD-86A4-D03F2BA1277E

P304

Q33736847-482BAD5B-3A56-4574-AA8B-69A460836FE3

P31

Q33736847-36FC0AD2-B7D5-4B43-864B-F65019288445

P356

Q33736847-1882645A-67F5-4899-B3E5-6124742BFE0B

P433

Q33736847-D23E3A04-F54F-4B11-902E-49B6F0FCF98D

P478

Q33736847-7F2D3335-A4E4-426B-BF25-C9E268DABBF9

P50

Q33736847-58236ACE-D254-446E-B263-AACDF05402C2

P577

Q33736847-AE2ED7D7-342E-4BB4-BEC5-365666E55557

P698

Q33736847-5382CE7E-8D15-4559-A3F8-53326ED37710

P932

Q33736847-F09D1472-CFDA-43F9-A366-1F393025E826

P356

P1433

Oman Medical Journal

P1476

Impact of Aberrant Myeloid Ant ...... l Acute Lymphoblastic Leukemia

@en

P2093

Arwa Al-Riyami

http://www.w3.org/2001/XMLSchema#string

Mohamed Al-Zaabi

http://www.w3.org/2001/XMLSchema#string

Mohammed Al-Huneini

http://www.w3.org/2001/XMLSchema#string

Muhanna Al-Muslahi

http://www.w3.org/2001/XMLSchema#string

Murtadha Al-Khabori

http://www.w3.org/2001/XMLSchema#string

Naglaa Fawaz

http://www.w3.org/2001/XMLSchema#string

Sulayma Al-Lamki

http://www.w3.org/2001/XMLSchema#string

P2860

Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

Treatment of acute lymphoblastic leukemia.

Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid-associated antigens.

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.

Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.

P304

189-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5001/OMJ.2017.36

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Salam Salim Amur Alkindi

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28584598

http://www.w3.org/2001/XMLSchema#string

P932

5447802

http://www.w3.org/2001/XMLSchema#string